# A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Source: https://onco.cc/trials/nct00006371/  
OnCo record `nct00006371` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Aminoglutethimide in Prostate cancer, run by H. Lee Moffitt Cancer Center and Research Institute, recorded as terminated on the registry.

## Summary

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer is a phase 2 interventional study registered as NCT00006371 by H. Lee Moffitt Cancer Center and Research Institute, with 2 participants recorded, started 2000-05 and due to reach its primary completion in 2001-12. Interventions recorded: aminoglutethimide, ketoconazole, therapeutic hydrocortisone. Conditions recorded: Prostate Cancer.

Linked to the drug Aminoglutethimide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00006371
- Phase: 2
- Setting: A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
- Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Enrolled: 2

## Sources

- ClinicalTrials.gov NCT00006371: https://clinicaltrials.gov/study/NCT00006371

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [Aminoglutethimide](https://onco.cc/drugs/aminoglutethimide/)

---
JSON: https://onco.cc/api/v1/entities/nct00006371.json